tiprankstipranks
Viking Therapeutics (DE:1VT)
FRANKFURT:1VT

Compare Viking Therapeutics (1VT) vs. Competitors

75 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Viking Therapeutics
€29.05
€3.34B
-6.36
47.22%
12 Buy
0 Hold
0 Sell
Strong Buy
Ultragenyx Pharmaceutical
$23.15
$2.24B
-3.94
-25.47%
17 Buy
2 Hold
0 Sell
Strong Buy
Xenon
$57.54
$5.49B
-10.27
103.83%
19 Buy
0 Hold
0 Sell
Strong Buy
Scholar Rock Holding
$49.99
$5.74B
-13.37
104.29%
13 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$24.61
$5.03B
-10.43
85.80%
10 Buy
2 Hold
0 Sell
Strong Buy
NewAmsterdam Pharma Company
$34.01
$3.91B
-19.69
124.34%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:1VT
Viking Therapeutics
29.15
10.63
57.43%
RARE
Ultragenyx Pharmaceutical
23.15
-10.76
-31.73%
XENE
Xenon
57.54
25.95
82.15%
SRRK
Scholar Rock Holding
49.99
22.93
84.74%
IMVT
Immunovant
24.73
9.83
65.97%
NAMS
NewAmsterdam Pharma Company
34.01
18.15
114.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts